Abstract
We review here the possible mechanisms of neuronal degeneration caused by L-cysteine, an odd excitotoxin. L-Cysteine lacks the omega carboxyl group required for excitotoxic actions via excitatory amino acid receptors, yet it evokes N-methyl-D-aspartate (NMDA) -like excitotoxic neuronal death and potentiates the Ca2+ influx evoked by NMDA. Both actions are prevented by NMDA antagonists. One target for cysteine effects is thus the NMDA receptor. The following mechanisms are discussed now: (1) possible increase in extracellular glutamate via release or inhibition of uptake/degradation, (2) generation of cysteine α-carbamate, a toxic analog of NMDA, (3) generation of toxic oxidized cysteine derivatives, (4) chelation of Zn2+ which blocks the NMDA receptor-ionophore, (5) direct interaction with the NMDA receptor redox site(s), (6) generation of free radicals, and (7) formation of S-nitrosocysteine. In addition to these, we describe another new alternative for cytotoxicity: (8) generation of the neurotoxic catecholamine derivative, 5-S-cysteinyl-3,4-dihydroxyphenylacetate (cysdopac).
Similar content being viewed by others
REFERENCES
Sagara, J., Miura, K., and Bannai, S. 1993. Maintenance of neuronal glutathione by glial cells. J. Neurochem. 61:1672-1676.
Kranich, O., Hamprecht, B., and Dringen, R. 1996. Different preferences in the utilization of amino acids for glutathione synthesis in cultured neurons and astroglial cells derived from rat brain. Neurosci. Lett. 219:211-214.
Dringen, R., Pfeiffer, B., and Hamprecht, B. 1999. Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J. Neurosci. 19:562-569.
Heafield, M. T., Fearn, S., Steventon, G. B., Waring, R. H., Williams, A. C., and Sturman, S. G. 1990. Plasma cysteine and sulphate levels in patients with motor neuron, Parkinson's and Alzheimer's disease. Neurosci. Lett. 110:216-220.
Miyamoto, M., Murphy, T. H., Schnaar, R. L., and Coyle, J. T. 1989. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J. Pharmacol. Exp. Ther. 250:1132-1140.
Bradbury, M. W. B. and Deane, R. 1993. Permeability of the blood-brain barrier to lead. Neurotoxicology 14:131-136.
Keller, H. J., Do, K. Q., Zollinger, M., Winterhalter, K. H., and Cuénod, M. 1989. Cysteine: depolarization-induced release from rat brain in vitro. J. Neurochem. 52:1801-1806.
Zängerle, L., Cuénod, M., Winterhalter, K. H., and Do, K. Q. 1992. Screening of thiol compounds: depolarization-induced release of glutathione and cysteine from rat brain slices. J. Neurochem. 59:181-189.
Olney, J. W., Zorumski, C., Price, M. T., and Labruyere, J. 1990. L-Cysteine, a bicarbonate-sensitive endogenous excitotoxin. Science 248:596-599.
Karlsen, R. L., Grofova, I., Malthe-Sorenssen, D., and Fonnum, F. 1981. Morphological changes in rat brain induced by L-cysteine injection in newborn animals. Brain Res. 208:167-180.
Klingman, J. G. and Choi, D. W. 1989. Toxicity of sulphur-containing amino acids on cultured cortical neurones. Neurology 39:397-398.
Olney, J. W. and Ho, O. L. 1970. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature 227:609-611.
Olney, J. W., Ho, O. L., Rhee, V., and Schainker, B. 1972. Cysteine-induced brain damage in infant and fetal rodents. Brain Res. 45:309-313.
Pedersen, O. O. and Karlsen, R. L. 1980. The toxic effect of L-cysteine on the rat retina. A morphological and biochemical study. Invest. Ophthalmol. Vis. Sci. 19:886-892.
Misra, C. H. 1989. Is a certain amount of cysteine prerequisite to produce brain damage in neonatal rats? Neurochem. Res. 14:253-257.
Olney, J. W. 1993. Role of excitotoxins in developmental neuropathology. APMIS 10 (Suppl. 40):103-112.
Sharpe, L. G., Olney, J. W., Ohlendorf, C., Lyss, A., Zimmerman, M., and Gale, B. 1975. Brain damage and associated behavioral deficits following the administration of L-cysteine to infant rats. Pharmacol. Biochem. Behav. 3:291-298.
Perry, T. L., Norman, M. G., Young, V. W., Whiting, S., Crichton, J. U., Hansen, S., and Kish, S. J. 1985. Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidums. Ann. Neurol. 18:482-489.
Lehmann, A., Hagberg, H., Orwar, O., and Sandberg, M. 1993. Cysteine sulphinate and cysteate: mediators of cysteine toxicity in the neonatal rat brain? Eur. J. Neurosci. 5:1398-1412.
Schurr, A., West, C. A., Heine, M. F., and Rigor, B. M. 1993. The neurotoxicity of sulfur-containing amino acids in energy-deprived rat hippocampal slices. Brain Res. 601:317-320.
Slivka, A. and Cohen, G. 1993. Brain ischemia markedly elevates levels of the neurotoxic amino acid, cysteine. Brain Res. 608:33-37.
Li, X, Wallin, C., Weber, S. G., and Sandberg, M. 1999. Net efflux of cysteine, glutathione and related metabolites from rat hippocampal slices during oxygen/glucose deprivation: dependence on γ-glutamyl transpeptidase. Brain Res. 815:81-88.
Madison, D. V., Malenka, R. C., and Nicoll, R. A., 1991. Mechanisms underlying long-term potentiation of synaptic transmission. Annu. Rev. Neurosci. 14:379-397.
Balázs, R. 1988. Metabolic imbalance and nerve cell damage in the brain. Prog. Brain Res. 73:447-461.
Choi, D. W. and Rothman, S. M. 1990. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13:171-182.
Rothman, S. M. and Olney, J. W. 1987. Excitotoxicity and the NMDA receptor. Trends Neurosci. 10:299-302.
Jesberger, J. A. and Richardson, J. S. 1991. Oxygen free radicals and brain dysfunction. Int. J. Neurosci. 57:1-17.
Choi, D. W. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634.
Mattson, M. P., Rydel, R. E., Lieberburg, I., and Smith-Swintosky, V. L. 1993. Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples. Ann. N.Y. Acad. Sci. 679:1-21.
Garthwaite, J., Charles, S. L., and Chess, W. R. 1988. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336:385-388.
Bredt, D. S., Hwang, P. M., and Snyder, S. H. 1990. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347:768-770.
Lipton, S. A. and Stamler, J. S. 1994. Actions of redox-related congeners of nitric oxide at the NMDA receptor. Neuropharmacology 33:1229-1233.
Puka-Sundvall, M., Eriksson, P., Nilsson, M., Sandberg, M., and Lehmann, A. 1995. Neurotoxicity of cysteine: interaction with glutamate. Brain Res. 705:65-70.
Pace, J. R., Martin, B. M., Paul, S. M., and Rogawski, M. A. 1992. High concentrations of neutral amino acids activate NMDA receptor currents in rat hippocampal neurons. Neurosci. Lett. 141:97-100.
Plaitakis, A., Smith, J., Mandel, J., and Yahr, M. D. 1988. Pilot trial of branched-chain aminoacids in amyotrophic lateral sclerosis. Lancet i:1015-1018.
Nath, K. A. and Salahudeen, A. K. 1993. Autooxidation of cysteine generates hydrogen peroxide: cytotoxicity and attenuation of pyruvate. Am. J. Physiol. 264:F306-F314.
D'Emilia, D. M. and Lipton, S. A. 1999. Ratio of S-nitrosohomocyst(e)ine to homocyst(e)ine or other thiols determines neurotoxicity in rat cerebrocortical cultures. Neurosci. Lett. 265:103-106.
Brorson, J. R. and Zhang, H. 1997. Disrupted [Ca2+]i homeostasis contributes to the toxicity of nitric oxide in cultured hippocampal neurons. J. Neurochem. 69:1882-1889.
Brorson, J. R., Sulit, R. A., and Zhang, H. 1997. Nitric oxide disrupts Ca2+homeostasis in hippocampal neurons. J. Neurochem. 68:95-105.
Lipton, S. A., Kim, W. K., Choi, Y. B., Kumar, S., D'Emilia, D. M., Raydu, P., Arnelle, D. R., and Stamler, J. S. 1997. Dual actions of homocysteine at the NMDA receptor. Proc. Natl. Acad. Sci. USA 94:5923-5928.
Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P., and Lipton, S. A. 1995. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA 92:7162-7166.
Lei, S. Z., Zhang, D., Abele, A. E., and Lipton, S. A. 1992. Blockade of NMDA receptor-mediated mobilization of intracellular Ca2+prevents neurotoxicity. Brain Res. 598:196-202.
Lipton, S. A., Choi, Y.-B., Pan, Z.-H., Lei S. Z., Chen, H.-S. V., Sucher, N. J., Loscalzo, J., Singel, D. J., and Stamler, J. S. 1993. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-632.
Colton, C. A., Pagan, F., Snell, J., Colton, J. S., Cummins, A., and Gilbert, D. L. 1995. Protection from oxidation enhances the survival of cultured mesencephalic neurons. Exp. Neurol. 132:54-61.
Ferkany, J. and Coyle, J. T. 1986. Heterogeneity of sodium-dependent excitatory amino acid uptake mechanisms in rat brain. J. Neurosci. Res. 16:491-503.
Gilman, S. C., Bonner, M. J., and Pellmar, T. C. 1994. Free radicals enhance basal release of D-[3H]aspartate from cerebral cortical synaptosomes. J. Neurochem. 62:1757-1763.
Volterra, A., Trotti, D., Tromba, C., Floridi, S., and Racagni, G. 1994. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14:2924-2932.
Taberner, P. V., Pearce, M. J., and Watkins, J. C. 1977. Inhibition of mouse brain glutamate decarboxylase by some structural analogues of L-glutamic acid. Biochem. Pharmacol. 26:345-349.
Aizenman, E., Lipton, S. A., and Loring, R. H., 1989. Selective modulation of NMDA responses by reduction and oxidation. Neuron 2:1257-1263.
Tang, L.-H. and Aizenman, E. 1993. Long-lasting modification of the N-methyl-D-aspartate receptor channel by a voltage-dependent sulfhydryl redox process. Mol. Pharmacol. 44:473-478.
Eimerl, S. and Schramm, M. 1992. An endogenous metal appears to regulate NMDA receptor mediated 45Ca2+influx and toxicity in cultured cerebellar granule cells. Neurosci. Lett. 137:198-202.
Eimerl, S. and Schramm, M. 1993 Potentiation of 45Ca uptake and acute toxicity mediated by the N-methyl-D-aspartate receptor: the effect of metal binding agents and transition metal ions. J. Neurochem. 61:518-525.
Hermann, A., Janáky, R., Dohovics, R., Saransaari, P., Oja, S. S., and Varga, V. 1999. Potentiation by L-cysteine of N-methyl-D-aspartate receptor: effects on intracellular free Ca2+in cultured cerebellar granule cells. Proc. West. Pharmacol. Soc. 42:25-26.
Olney, J. W., Misra, C. H., and deGubareff, T. 1975. Cysteine-Ssulfate: brain damaging metabolite in sulfite oxidase deficiency. J. Neuropath. Exp. Neurol. 34:167-176.
Olney, J. W., Ho, O. L., and Rhee, V. 1971. Cytotoxic effects of acidic and sulphur-containing amino acids on the infant mouse central nervous system. Exp. Brain Res. 14:61-76.
Patneau, D. K. and Mayer, M. L. 1990. Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J. Neurosci. 10:2385-2399.
Porter, R. H. P. and Roberts, P. J. 1993. Glutamate metabotropic receptor activation in neonatal rat cerebral cortex by sulphur-containing excitatory amino acids. Neurosci. Lett. 154:78-80.
Griffiths, R. 1990. Cysteine sulphinate (CSA) as an excitatory amino acid transmitter candidate in the mammalian central nervous system. Prog. Neurobiol. 35:313-323.
Griffiths, R., Malcolm, C., Ritchie, L., Frandsen, A., Schousboe, A., Scott, M., Rumsby, P., and Meredith, C. 1997. Association of c-fos mRNA expression and excitotoxicity in primary cultures of mouse neocortical and cerebellar neurons. J. Neurosci. Res. 48:533-542.
Griffiths, R., Grieve, A., Dunlop, J., Damgaard, I., Fosmark, D., and Schousboe, A. 1989. Inhibition by excitatory sulphur amino acids of the high-affinity L-glutamate transporter in synaptosomes and in primary cultures of cortical astrocytes and cerebellar neurons. Neurochem. Res. 14:313-323.
Boss, V., Nutt, K. M., and Conn, P. J. 1994. L-Cysteine sulfinic acid as an endogenous agonist of a novel metabotropic receptor coupled to stimulation of phospholipase D activity. Mol. Pharmacol. 45:1177-1182.
Watkins, J. C. 1978. Excitatory amino acids. Pages 37-69, in McGeer, E. G. (ed.), Kainic Acid as a Tool in Neurobiology, Raven, New York
Andiné, P., Orwar, O., Jacobson, I., Sandberg, M., and Hagberg, H. 1991. Extracellular acidic sulfur-containing amino acids and gamma-glutamyl peptides in global ischemia: postischemic recovery of neuronal activity is paralleled by a tetrodotoxin-sensitive increase in cysteine sulfinate in the CA1 of the rat hippocampus. J. Neurochem. 57:230-236.
Nunn, P. B., Davis, A. J., and O'Brien, P. 1991. Carbamate formation and the neurotoxicity of L-α-amino acids. Science 251:1619.
Max, B. 1991. This and that: the neurotoxicity of carbon dioxide. Trends Pharmacol. Sci. 12:408-411.
Alagarsamy, S., Philips, M., Pappas, T., and Johnson, K. M. 1997. Dopamine neurotoxicity in cortical neurons. Drug Alcohol Depend. 48:105-111.
Cheng, N., Maeda, T., Kume, T., Kaneko, S., Kochiyama, H., Akaike, A., Goshima, Y., and Misu, Y. 1996. Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons. Brain Res. 743:278-283.
Noh, J. S., Kim, E. Y., Kang, J. S., Kim, H. R., Oh, Y. J., and Gwag, B. J. 1999. Neurotoxic and neuroprotective actions of catecholamines in cortical neurons. Exp. Neurol. 159:217-224.
Montine, T. J., Picklo, M. J., Amarnath, V., Whetsell, W. O. Jr., and Graham, D. G. 1997. Neurotoxicity of endogenous cysteinyl-catechols. Exp. Neurol. 148:26-33.
Hoyt, K. R., Reynolds, I. J., and Hastings, T. G. 1997. Mechanisms of dopamine-induced cell death in cultured rat forebrain neurons: interactions with and differences from glutamate-induced cell death. Exp. Neurol. 143:269-281.
Greenamyre, J. T. and O'Brien, C. F. 1991. N-Methyl-D-aspartate antagonists in the treatment of Parkinson's disease. Arch. Neurol. 48:977-981.
Han, J., Cheng, F.-C., Yang, Z., and Dryhurst, G. 1999. Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease. J. Neurochem. 73:1683-1695.
Li, H. and Dryhurst, G. 1997. Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxylic acid (DHBT-1): a putative nigral endotoxin of relevance to Parkinson's disease. J. Neurochem. 69:1530-1541.
Li, H., Shen, X.-M., and Dryhurst, G. 1998. Brain mitochondria catalyze the oxidation of 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxylic acid (DHBT-1) to intermediates that irreversibly inhibit complex I and scavenge glutathione: potential relevance to the pathogenesis of Parkinson's disease. J. Neurochem. 71:2049-2062.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Janáky, R., Varga, V., Hermann, A. et al. Mechanisms of L-Cysteine Neurotoxicity. Neurochem Res 25, 1397–1405 (2000). https://doi.org/10.1023/A:1007616817499
Issue Date:
DOI: https://doi.org/10.1023/A:1007616817499